These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21067504)

  • 1. Estrogens and progression of diabetic kidney damage.
    Doublier S; Lupia E; Catanuto P; Elliot SJ
    Curr Diabetes Rev; 2011 Jan; 7(1):28-34. PubMed ID: 21067504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogens and the diabetic kidney.
    Maric C; Sullivan S
    Gend Med; 2008; 5 Suppl A(Suppl A):S103-13. PubMed ID: 18395675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex, diabetes and the kidney.
    Maric C
    Am J Physiol Renal Physiol; 2009 Apr; 296(4):F680-8. PubMed ID: 19144692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RTN1 mediates progression of kidney disease by inducing ER stress.
    Fan Y; Xiao W; Li Z; Li X; Chuang PY; Jim B; Zhang W; Wei C; Wang N; Jia W; Xiong H; Lee K; He JC
    Nat Commun; 2015 Jul; 6():7841. PubMed ID: 26227493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autocrine activation of the local insulin-like growth factor I system is up-regulated by estrogen receptor (ER)-independent estrogen actions and accounts for decreased ER expression in type 2 diabetic mesangial cells.
    Karl M; Potier M; Schulman IH; Rivera A; Werner H; Fornoni A; Elliot SJ
    Endocrinology; 2005 Feb; 146(2):889-900. PubMed ID: 15550505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycogen synthase kinase 3β hyperactivity in urinary exfoliated cells predicts progression of diabetic kidney disease.
    Liang X; Wang P; Chen B; Ge Y; Gong AY; Flickinger B; Malhotra DK; Wang LJ; Dworkin LD; Liu Z; Gong R
    Kidney Int; 2020 Jan; 97(1):175-192. PubMed ID: 31791666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LRG1 Promotes Diabetic Kidney Disease Progression by Enhancing TGF-
    Hong Q; Zhang L; Fu J; Verghese DA; Chauhan K; Nadkarni GN; Li Z; Ju W; Kretzler M; Cai GY; Chen XM; D'Agati VD; Coca SG; Schlondorff D; He JC; Lee K
    J Am Soc Nephrol; 2019 Apr; 30(4):546-562. PubMed ID: 30858225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome loses its predictive power in late-stage chronic kidney disease progression--a paradoxical phenomenon.
    Lee CC; Sun CY; Wu IW; Wang SY; Wu MS
    Clin Nephrol; 2011 Feb; 75(2):141-9. PubMed ID: 21255544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of diabetic nephropathy. Insights from cell culture studies and animal models.
    Phillips A; Janssen U; Floege J
    Kidney Blood Press Res; 1999; 22(1-2):81-97. PubMed ID: 10352411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRPC6 channel as an emerging determinant of the podocyte injury susceptibility in kidney diseases.
    Ilatovskaya DV; Staruschenko A
    Am J Physiol Renal Physiol; 2015 Sep; 309(5):F393-7. PubMed ID: 26084930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Impaired Nutrient and Oxygen Deprivation Signaling and Deficient Autophagic Flux in Diabetic CKD Development: Implications for Understanding the Effects of Sodium-Glucose Cotransporter 2-Inhibitors.
    Packer M
    J Am Soc Nephrol; 2020 May; 31(5):907-919. PubMed ID: 32276962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex Differences in Diabetic Kidney Disease.
    Maric-Bilkan C
    Mayo Clin Proc; 2020 Mar; 95(3):587-599. PubMed ID: 32138885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of chronic renal disease.
    Klahr S
    Heart Dis; 2001; 3(3):205-9. PubMed ID: 11975793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Altered Uric Acid Metabolism Contribute to Diabetic Kidney Disease Pathophysiology?
    Gul A; Zager P
    Curr Diab Rep; 2018 Mar; 18(4):18. PubMed ID: 29497863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen receptor alpha-mediated events promote sex-specific diabetic glomerular hypertrophy.
    Lovegrove AS; Sun J; Gould KA; Lubahn DB; Korach KS; Lane PH
    Am J Physiol Renal Physiol; 2004 Sep; 287(3):F586-91. PubMed ID: 15149972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender and the prevalence and progression of renal disease.
    Neugarten J; Golestaneh L
    Adv Chronic Kidney Dis; 2013 Sep; 20(5):390-5. PubMed ID: 23978543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex differences in progression of diabetic nephropathy in OVE26 type 1 diabetic mice.
    Wang W; Jiang S; Tang X; Cai L; Epstein PN; Cheng Y; Sun W; Xu Z; Tan Y
    Biochim Biophys Acta Mol Basis Dis; 2020 Jan; 1866(1):165589. PubMed ID: 31678163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmentation of kidney injury by basic fibroblast growth factor or platelet-derived growth factor does not induce progressive diabetic nephropathy in the Goto Kakizaki model of non-insulin-dependent diabetes.
    Riley SG; Steadman R; Williams JD; Floege J; Phillips AO
    J Lab Clin Med; 1999 Sep; 134(3):304-12. PubMed ID: 10482316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic kidney disease and the involvement of estrogen hormones in its pathogenesis and progression.
    Gluhovschi G; Gluhovschi A; Anastasiu D; Petrica L; Gluhovschi C; Velciov S
    Rom J Intern Med; 2012; 50(2):135-44. PubMed ID: 23326957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidants in chronic kidney disease.
    Shah SV; Baliga R; Rajapurkar M; Fonseca VA
    J Am Soc Nephrol; 2007 Jan; 18(1):16-28. PubMed ID: 17167116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.